DNMT3A and acute myeloid leukemia: In conclusion, we identified a DNMT3A-R882H neoantigen presented on patient-derived AML cells by HLA-DQB1*06:02 and -DQB1*06:03 that is recognized by a CD4 T cell clone, which is not able to kill AML cells.